Pharmacokinetic/pharmacodynamic model of the testosterone effects of triptorelin administered in sustained release formulations in patients with prostate cancer.

Pharmacokinetic/pharmacodynamic model of the testosterone effects of triptorelin administered in sustained release formulations in patients with prostate cancer.

Item
http://www.wikidata.org/entity/Q43693658
An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate CancerTime and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice.Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancerCharacterization of 12 GnRH peptide agonists - a kinetic perspectiveMathematical model approach to describe tumour response in mice after vaccine administration and its applicability to immune-stimulatory cytokine-based strategiesThe designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor.A population pharmacodynamic model for lactate dehydrogenase and neuron specific enolase to predict tumor progression in small cell lung cancer patients.Population Pharmacokinetic Analysis of Lanreotide Autogel/Depot in the Treatment of Neuroendocrine Tumors: Pooled Analysis of Four Clinical Trials.Current challenges in peptide-based drug discovery.Mathematical modeling of efficacy and safety for anticancer drugs clinical development.Optimal dynamic control approach in a multi-objective therapeutic scenario: Application to drug delivery in the treatment of prostate cancer.Expression of progenitor markers is associated with the functionality of a bioartificial adrenal cortex.A semi-mechanistic integrated pharmacokinetic/pharmacodynamic model of the testosterone effects of the gonadotropin-releasing hormone agonist leuprolide in prostate cancer patients.
P2860

Pharmacokinetic/pharmacodynamic model of the testosterone effects of triptorelin administered in sustained release formulations in patients with prostate cancer.

Item
http://www.wikidata.org/entity/Q43693658
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Pharmacokinetic/pharmacodynami ...... patients with prostate cancer.
@en
Pharmacokinetic/pharmacodynami ...... patients with prostate cancer.
@nl
type
label
Pharmacokinetic/pharmacodynami ...... patients with prostate cancer.
@en
Pharmacokinetic/pharmacodynami ...... patients with prostate cancer.
@nl
prefLabel
Pharmacokinetic/pharmacodynami ...... patients with prostate cancer.
@en
Pharmacokinetic/pharmacodynami ...... patients with prostate cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Pharmacokinetic/pharmacodynami ...... patients with prostate cancer.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698